Amundi Asset Management US’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$8.76M Buy
504,287
+4,728
+0.9% +$83.1K 0.01% 878
2020
Q4
$8.68M Buy
499,559
+341,617
+216% +$5.45M 0.01% 851
2020
Q3
$2.18M Sell
157,942
-16,013
-9% -$235K ﹤0.01% 1083
2020
Q2
$2.51M Buy
173,955
+57,008
+49% +$749K ﹤0.01% 1022
2020
Q1
$1.28M Sell
116,947
-3,478
-3% -$64.1K ﹤0.01% 1051
2019
Q4
$2.57M Buy
120,425
+7,573
+7% +$170K ﹤0.01% 1077
2019
Q3
$2.59M Buy
112,852
+7,682
+7% +$164K ﹤0.01% 1040
2019
Q2
$2.07M Sell
105,170
-3,862
-4% -$75.3K ﹤0.01% 1132
2019
Q1
$2.12M Sell
109,032
-6,309
-5% -$120K ﹤0.01% 1081
2018
Q4
$1.9K Sell
115,341
-175,249
-60% -$3.53M ﹤0.01% 1050
2018
Q3
$6.72M Sell
290,590
-18,473
-6% -$419K 0.01% 828
2018
Q2
$6.72M Buy
309,063
+24,095
+8% +$471K 0.01% 839
2018
Q1
$5.03M Buy
284,968
+98,532
+53% +$1.74M 0.01% 856
2017
Q4
$3.5M Buy
+186,436
New +$3.71M 0.01% 944

Other funds holding SBRA

Amundi Asset Management US's SBRA Position: Q1 2021 in Review

Amundi Asset Management US increased its Sabra Healthcare REIT (SBRA) stake by 0.95% in Q1 2021, buying an estimated $83.1K and bringing the position to 504,287 shares worth $8.76M. The position accounts for 0.01% of the portfolio, ranked #878.

Amundi Asset Management US first reported a position in SBRA in Q4 2017 and has held it in 14 quarters since. 333 funds tracked by Wall St. Rank hold SBRA as of Q1 2021.

  • Amundi Asset Management US held 504,287 shares of Sabra Healthcare REIT worth $8.76M as of Q1 2021.
  • Amundi Asset Management US bought 4,728 Sabra Healthcare REIT shares in Q1 2021, an estimated $83.1K.
  • Sabra Healthcare REIT made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #878 holding.
  • Amundi Asset Management US first reported a position in Sabra Healthcare REIT in Q4 2017 and has held it in 14 quarters since.
  • 333 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.